Cargando…

Clinical experience with the treatment of retroperitoneal vascular leiomyosarcoma originating from large veins

BACKGROUND: Retroperitoneal vascular leiomyosarcoma (RVLMS) is an extremely rare disease in clinical practice, and it has poor prognosis. This article is to explore the diagnosis and treatment of RVLMS and present our experience. METHODS: Data of RVLMS patients were continuously collected in our hos...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hong-xian, Wang, Kai, Hong, Peng, Lu, Min, Liu, Zhuo, Liu, Lei, Wang, Guo-liang, Ma, Lu-lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364698/
https://www.ncbi.nlm.nih.gov/pubmed/34392834
http://dx.doi.org/10.1186/s12893-021-01322-z
_version_ 1783738568621948928
author Zhang, Hong-xian
Wang, Kai
Hong, Peng
Lu, Min
Liu, Zhuo
Liu, Lei
Wang, Guo-liang
Ma, Lu-lin
author_facet Zhang, Hong-xian
Wang, Kai
Hong, Peng
Lu, Min
Liu, Zhuo
Liu, Lei
Wang, Guo-liang
Ma, Lu-lin
author_sort Zhang, Hong-xian
collection PubMed
description BACKGROUND: Retroperitoneal vascular leiomyosarcoma (RVLMS) is an extremely rare disease in clinical practice, and it has poor prognosis. This article is to explore the diagnosis and treatment of RVLMS and present our experience. METHODS: Data of RVLMS patients were continuously collected in our hospital from August 2018 to February 2020: two males and two females with a median age of 56 (min–max = 33–61) years were included. Patients in whom paraganglioma could not be excluded were asked to take phenoxybenzamine before surgery. A multi-disciplinary team (MDT) meeting had been held and surgery was recommended. The operation procedures varied based on the tumor location, shape, and stage, and the core steps were "exposure of the retroperitoneum and tumor, identification of vital blood vessels, blocking the bloodstream, complete removal of the tumor and tumor thrombus, and release of blood flow". A Satinsky clamp was used to partially block the blood vessels. Follow-up was conveyed by revisits and phone calls. RESULTS: One patient underwent open surgery, and three patients underwent laparoscopic surgery, one of whom underwent conversion to open surgery. The procedures were finished successfully, with a median operative time of 314.5 (min–max = 224–467) mins. The median amount of intraoperative bleeding was 550 (min–max = 200–1500) ml, and three patients had transfusion during the operation. The mass was irregular in shape, with a median maximum size of 7.45 (min–max = 4.2–10.7) cm, and the pathological examination confirmed RVLMS, which has spindle-shape, high mitotic activity and atypia. One week after the operation, the median serum creatinine level was 85 (min–max = 70–99) µmol/L. The median follow-up time was 16 (min–max = 13–21) months, and 1 case reported asymptomatic recurrence. CONCLUSION: Uncharacteristic manifestations and imaging features contribute to the problematic diagnosis of RVLMS. Comprehensive preoperative evaluation and careful surgical planning are essential. Multicenter research is needed in the future to reach a dominant consensus.
format Online
Article
Text
id pubmed-8364698
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-83646982021-08-17 Clinical experience with the treatment of retroperitoneal vascular leiomyosarcoma originating from large veins Zhang, Hong-xian Wang, Kai Hong, Peng Lu, Min Liu, Zhuo Liu, Lei Wang, Guo-liang Ma, Lu-lin BMC Surg Research BACKGROUND: Retroperitoneal vascular leiomyosarcoma (RVLMS) is an extremely rare disease in clinical practice, and it has poor prognosis. This article is to explore the diagnosis and treatment of RVLMS and present our experience. METHODS: Data of RVLMS patients were continuously collected in our hospital from August 2018 to February 2020: two males and two females with a median age of 56 (min–max = 33–61) years were included. Patients in whom paraganglioma could not be excluded were asked to take phenoxybenzamine before surgery. A multi-disciplinary team (MDT) meeting had been held and surgery was recommended. The operation procedures varied based on the tumor location, shape, and stage, and the core steps were "exposure of the retroperitoneum and tumor, identification of vital blood vessels, blocking the bloodstream, complete removal of the tumor and tumor thrombus, and release of blood flow". A Satinsky clamp was used to partially block the blood vessels. Follow-up was conveyed by revisits and phone calls. RESULTS: One patient underwent open surgery, and three patients underwent laparoscopic surgery, one of whom underwent conversion to open surgery. The procedures were finished successfully, with a median operative time of 314.5 (min–max = 224–467) mins. The median amount of intraoperative bleeding was 550 (min–max = 200–1500) ml, and three patients had transfusion during the operation. The mass was irregular in shape, with a median maximum size of 7.45 (min–max = 4.2–10.7) cm, and the pathological examination confirmed RVLMS, which has spindle-shape, high mitotic activity and atypia. One week after the operation, the median serum creatinine level was 85 (min–max = 70–99) µmol/L. The median follow-up time was 16 (min–max = 13–21) months, and 1 case reported asymptomatic recurrence. CONCLUSION: Uncharacteristic manifestations and imaging features contribute to the problematic diagnosis of RVLMS. Comprehensive preoperative evaluation and careful surgical planning are essential. Multicenter research is needed in the future to reach a dominant consensus. BioMed Central 2021-08-15 /pmc/articles/PMC8364698/ /pubmed/34392834 http://dx.doi.org/10.1186/s12893-021-01322-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhang, Hong-xian
Wang, Kai
Hong, Peng
Lu, Min
Liu, Zhuo
Liu, Lei
Wang, Guo-liang
Ma, Lu-lin
Clinical experience with the treatment of retroperitoneal vascular leiomyosarcoma originating from large veins
title Clinical experience with the treatment of retroperitoneal vascular leiomyosarcoma originating from large veins
title_full Clinical experience with the treatment of retroperitoneal vascular leiomyosarcoma originating from large veins
title_fullStr Clinical experience with the treatment of retroperitoneal vascular leiomyosarcoma originating from large veins
title_full_unstemmed Clinical experience with the treatment of retroperitoneal vascular leiomyosarcoma originating from large veins
title_short Clinical experience with the treatment of retroperitoneal vascular leiomyosarcoma originating from large veins
title_sort clinical experience with the treatment of retroperitoneal vascular leiomyosarcoma originating from large veins
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364698/
https://www.ncbi.nlm.nih.gov/pubmed/34392834
http://dx.doi.org/10.1186/s12893-021-01322-z
work_keys_str_mv AT zhanghongxian clinicalexperiencewiththetreatmentofretroperitonealvascularleiomyosarcomaoriginatingfromlargeveins
AT wangkai clinicalexperiencewiththetreatmentofretroperitonealvascularleiomyosarcomaoriginatingfromlargeveins
AT hongpeng clinicalexperiencewiththetreatmentofretroperitonealvascularleiomyosarcomaoriginatingfromlargeveins
AT lumin clinicalexperiencewiththetreatmentofretroperitonealvascularleiomyosarcomaoriginatingfromlargeveins
AT liuzhuo clinicalexperiencewiththetreatmentofretroperitonealvascularleiomyosarcomaoriginatingfromlargeveins
AT liulei clinicalexperiencewiththetreatmentofretroperitonealvascularleiomyosarcomaoriginatingfromlargeveins
AT wangguoliang clinicalexperiencewiththetreatmentofretroperitonealvascularleiomyosarcomaoriginatingfromlargeveins
AT malulin clinicalexperiencewiththetreatmentofretroperitonealvascularleiomyosarcomaoriginatingfromlargeveins